Artelo biosciences announces important new data on art26.12 demonstrating positive effects in multiple models of neuropathic pain at the 33rd annual international cannabinoid research society symposium

Art26.12, a novel fatty acid binding protein 5 (fabp5) inhibitor, shows favorable results in studies for chemotherapy-induced neuropathy and diabetic neuropathy
ARTL Ratings Summary
ARTL Quant Ranking